BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 19785513)

  • 21. Nuclear receptors in regulation of biotransformation enzymes and drug transporters in the placental barrier.
    Pavek P; Smutny T
    Drug Metab Rev; 2014 Feb; 46(1):19-32. PubMed ID: 24020384
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transporter-mediated drug-drug interactions.
    Zhang L; Huang SM; Lesko LJ
    Clin Pharmacol Ther; 2011 Apr; 89(4):481-4. PubMed ID: 21423238
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Placental transporters relevant to drug distribution across the maternal-fetal interface.
    Ganapathy V; Prasad PD; Ganapathy ME; Leibach FH
    J Pharmacol Exp Ther; 2000 Aug; 294(2):413-20. PubMed ID: 10900213
    [No Abstract]   [Full Text] [Related]  

  • 24. The role of xenobiotic-metabolizing enzymes in the placenta: a growing research field.
    Blanco-Castañeda R; Galaviz-Hernández C; Souto PCS; Lima VV; Giachini FR; Escudero C; Damiano AE; Barragán-Zúñiga LJ; Martínez-Aguilar G; Sosa-Macías M
    Expert Rev Clin Pharmacol; 2020 Mar; 13(3):247-263. PubMed ID: 32129110
    [No Abstract]   [Full Text] [Related]  

  • 25. L-carnitine is synthesized in the human fetal-placental unit: potential roles in placental and fetal metabolism.
    Oey NA; van Vlies N; Wijburg FA; Wanders RJ; Attie-Bitach T; Vaz FM
    Placenta; 2006 Aug; 27(8):841-6. PubMed ID: 16300828
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterisation of the xenobiotic-metabolizing Cytochrome P450 expression pattern in human lung tissue by immunochemical and activity determination.
    Bernauer U; Heinrich-Hirsch B; Tönnies M; Peter-Matthias W; Gundert-Remy U
    Toxicol Lett; 2006 Jul; 164(3):278-88. PubMed ID: 16483733
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regulation of transporters by nuclear hormone receptors: implications during inflammation.
    Teng S; Piquette-Miller M
    Mol Pharm; 2008; 5(1):67-76. PubMed ID: 18072749
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of divalent metal transporter 1 (DMT1) isoforms in first trimester human placenta and embryonic tissues.
    Chong WS; Kwan PC; Chan LY; Chiu PY; Cheung TK; Lau TK
    Hum Reprod; 2005 Dec; 20(12):3532-8. PubMed ID: 16123094
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The presence of xenobiotic transporters in rat placenta.
    Leazer TM; Klaassen CD
    Drug Metab Dispos; 2003 Feb; 31(2):153-67. PubMed ID: 12527696
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of xenobiotic transporters in bacterial drug resistance and virulence.
    Nishino K; Yamaguchi A
    IUBMB Life; 2008 Sep; 60(9):569-74. PubMed ID: 18481812
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Animal models of xenobiotic receptors in drug metabolism and diseases.
    Gong H; Sinz MW; Feng Y; Chen T; Venkataramanan R; Xie W
    Methods Enzymol; 2005; 400():598-618. PubMed ID: 16399373
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Induction of cytochrome P450 isozymes by phenobarbital in pregnant rat and fetal livers and placenta.
    Ejiri N; Katayama K; Doi K
    Exp Mol Pathol; 2005 Apr; 78(2):150-5. PubMed ID: 15713442
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of prostaglandin transporter in the bovine uterus and fetal membranes during pregnancy.
    Banu SK; Arosh JA; Chapdelaine P; Fortier MA
    Biol Reprod; 2005 Aug; 73(2):230-6. PubMed ID: 15814899
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Glucose transporters in the human placenta.
    Illsley NP
    Placenta; 2000 Jan; 21(1):14-22. PubMed ID: 10692246
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Coordinate transcriptional regulation of transport and metabolism.
    Eloranta JJ; Meier PJ; Kullak-Ublick GA
    Methods Enzymol; 2005; 400():511-30. PubMed ID: 16399367
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of the multidrug resistance P-glycoprotein, (ABCB1 glycoprotein) in the human placenta decreases with advancing gestation.
    Sun M; Kingdom J; Baczyk D; Lye SJ; Matthews SG; Gibb W
    Placenta; 2006; 27(6-7):602-9. PubMed ID: 16143395
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human placenta metabolizes fatty acids: implications for fetal fatty acid oxidation disorders and maternal liver diseases.
    Shekhawat P; Bennett MJ; Sadovsky Y; Nelson DM; Rakheja D; Strauss AW
    Am J Physiol Endocrinol Metab; 2003 Jun; 284(6):E1098-105. PubMed ID: 12582009
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Drug transport across the placenta, role of the ABC drug efflux transporters.
    Behravan J; Piquette-Miller M
    Expert Opin Drug Metab Toxicol; 2007 Dec; 3(6):819-30. PubMed ID: 18028027
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alterations in drug disposition during pregnancy: implications for drug therapy.
    Hodge LS; Tracy TS
    Expert Opin Drug Metab Toxicol; 2007 Aug; 3(4):557-71. PubMed ID: 17696806
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The unique characteristics of the placental transcriptome and the hormonal metabolism enzymes in placenta.
    Storvik M; Huuskonen P; Pehkonen P; Pasanen M
    Reprod Toxicol; 2014 Aug; 47():9-14. PubMed ID: 24814680
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.